Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Solid Therapeutics ApS
APS
Active
CVR 43007068
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2022 · 4 years old
3 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Solid Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
TM
Thomas Michael Frimurer
Founder
Founder
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
CH
Claus Haase
Board of Directors
Board of Directors
2022
TW
Thue Walter Schwartz
Board of Directors
Board of Directors
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Frimurer Holdings ApS
Company
20–24.99%
20–24.99%
2022
Receptor Holding ApS
Company
20–24.99%
20–24.99%
2022
Anne Mette Hyldgaard Trauelsen
Individual
20–24.99%
20–24.99%
2023
Hagop Youssoufian
Individual
10–14.99%
10–14.99%
2023
Haase Invest ApS
Company
10–14.99%
10–14.99%
2022
Stine Helene Falsig Petersen
Individual
10–14.99%
10–14.99%
2023
John Sørensen Haurum
Individual
10–14.99%
10–14.99%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Solid Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network